Epigenomics said this week that current Chief Financial Officer Oliver Schacht will be leaving the company by the end of the first quarter 2011.
Schacht co-founded Epigenomics in 1998 and began his work as CFO in 1999. He has also served as CEO of Epigenomics' US subsidiary in Seattle since January 2006. Prior to joining Epigenomics, Schacht was a consultant with Mercer Management Consulting. He also founded or co-founded several companies, including TherEpi. He holds a Master's Degree and PhD from the University of Cambridge.